Commentary

“Wake up and smell the fiber” is the continuing battle cry of columnist James Carlini, and he's at it again. In this rather combative edition of Carlini's Comments, he points out that the need for speed is a very patriotic concept, and the lack thereof...

Inside Wisconsin columnist Tom Still recommends a little “back to the future” as he explains the many ways Wisconsin can use its technological expertise to launch a proposed space camp on the moon. Whether America will book a return trip to its only satellite remains...

With the changing rules of search, the highest bidder may get into the game, but there is no guarantee of a winning hand, according to Tech/Know columnist Troy Janisch. To make sure your ads reach the top, he recommends that you pay close attention to...

In her most recent column, DEMO Letter author Chris Shipley asked her readers for their 2007 predictions, and they really delivered. From forecasts of an electronic privacy meltdown to a louder wake-up call for Web 2.0, their unpredictable predictions make for required - and entertaining...

The link between education and earnings has been acknowledged for some time, but the Wisconsin Taxpayers Alliance has given it a local emphasis, writes Inside Wisconsin columnist Tom Still. The disparity in educational attainment between residents of Madison and Milwaukee, and the resulting wage gap...

A waiver policy by the United States Department of Justice is putting companies in a bind when investigating wrong doing in their organizations. In this third installment of Boardroom Perspectives, attorney John Fons calls on executive leaders to support a proposed bill that would curb...

Fearless forecaster Chris Shipley, author of the DEMO Letter, offers her 2007 technology predictions and invites readers to do the same. Among her forecasts is the belief that the hype surrounding Web 2.0 will fade, and that businesses will once again capture the attention of...

Even after some the most widely publicized corporate scandals in American history, the boards of directors of too many companies are headed down a slippery slope, according to columnist Ron Kral. In this installment of Boardroom Perspectives, he warns that business boards must assert themselves...

You'll have to excuse drug companies if they feel caught in a vice between those who want to make "big pharma" a political bogeyman and consumers who want too much, too soon. In the latest Inside Wisconsin, Tom Still points to a Tufts University study...